Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
Baiza-Durán L, Olvera-Montaño O, Mercado-Sesma AR, Oregon-Miranda AA, Lizárraga-Corona A, Ochoa-Tabares JC, Pérez-Balbuena AL, Montoya-Sánchez IM, Saucedo-Rodríguez LR, Mora-González A, Gómez-Bastar PA, Villanueva-Najera MA, Sandoval-Delgadillo LI, González-Lomelí M, Páez-Garza JH, Orozco-Carroll M, Casillas-Magallanes M. Baiza-Durán L, et al. Among authors: gomez bastar pa. J Ocul Pharmacol Ther. 2018 Apr;34(3):250-255. doi: 10.1089/jop.2017.0056. Epub 2018 Jan 11. J Ocul Pharmacol Ther. 2018. PMID: 29624493 Clinical Trial.
Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
Baiza-Duran LM, Quintana-Hau J, Tornero-Montaño R, Ortiz MI, Castañeda-Hernández G, Alanis-Villarreal L, Avalos-Urzua G, Bustos-Zermeño R, Domene-Hinojosa JL, Gómez-Bastar P, Ibañez-Hernandez MA, Morales-Gómez ME, Velasco-Gallegos G, Villar-Kuri J. Baiza-Duran LM, et al. Int J Clin Pharmacol Ther. 2009 Feb;47(2):89-95. doi: 10.5414/cpp47089. Int J Clin Pharmacol Ther. 2009. PMID: 19203564 Clinical Trial.
Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation.
Gonzalez JR, Baiza-Duran L, Quintana-Hau J, Tornero-Montaño R, Castaneda-Hernandez G, Ortiz M, Alarcon-Oceguera F, Beltran-Loustaunau M, Cortez-Gastelum M, Garcidueñas-Mejia J, Gomez-Bastar P, Jimenez-Roman J, Korder-Ortega V, Paczka-Zapata J, Torres-Segura M, Velasco-Gallegos G. Gonzalez JR, et al. J Clin Pharmacol. 2007 Jan;47(1):121-6. doi: 10.1177/0091270006292626. J Clin Pharmacol. 2007. PMID: 17192510 Clinical Trial.
The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
Baiza-Durán LM, Alvarez-Delgado J, Contreras-Rubio AY, Medrano-Palafox J, De Luca-Brown A, Casab-Rueda H, Cortés-Gastélum MA, Garcidueñas-Mejía MJ, Gómez-Bastar P, Gil-Carrasco F, Hartleben-Matkin C, Jiménez-Román J, Moreno-Marín ML, Paczka-Zapata JA, Velasco-Gallegos G, Vergara-Sinta M. Baiza-Durán LM, et al. Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):174-8. Ann Ophthalmol (Skokie). 2009. PMID: 20214051 Clinical Trial.
Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014.
Lopez-Ramos A, Gomez-Bastar PA, Lansingh VC, Rodriguez-Gomez JA, Vargas-Fragoso V, Soria-Arellano FA, Silva-Camacho SH, Castillo-Velazquez J, Zepeda-Romero LC, Limburg H. Lopez-Ramos A, et al. Among authors: gomez bastar pa. Ophthalmic Epidemiol. 2018 Oct-Dec;25(5-6):412-418. doi: 10.1080/09286586.2018.1501498. Epub 2018 Aug 6. Ophthalmic Epidemiol. 2018. PMID: 30081687
Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries.
McCormick I, Butcher R, Evans JR, Mactaggart IZ, Limburg H, Jolley E, Sapkota YD, Oye JE, Mishra SK, Bastawrous A, Furtado JM, Joshi A, Xiao B, Ravilla TD, Bourne RRA, Cieza A, Keel S, Burton MJ, Ramke J; RAAB International Co-Author Group. McCormick I, et al. Lancet Glob Health. 2022 Dec;10(12):e1744-e1753. doi: 10.1016/S2214-109X(22)00419-3. Epub 2022 Oct 11. Lancet Glob Health. 2022. PMID: 36240806 Free article.
Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries.
Bourne RRA, Cicinelli MV, Sedighi T, Tapply IH, McCormick I, Jonas JB, Congdon NG, Ramke J, Naidoo KS, Fricke TR, Burton MJ, Müller A, Bikbov MM, Furtado JM, Kyari F, He M, Wang YX, Vijaya L, Nangia V, Brian G, Emamian MH, Fotouhi A, Hashemi H, Khandekar RB, Marmamula S, Salomão S, George R, Kazakbaeva G, Braithwaite T, Casson RJ, Iwase A, Gupta N, Abdianwall MH, Varma R, Wong TY, Wang N, Taylor HR, Flaxman SR, Keel S, Resnikoff S; Vision Loss Expert Group of the Global Burden of Disease Study; RAAB International Co-Author Group. Bourne RRA, et al. Lancet Glob Health. 2022 Dec;10(12):e1754-e1763. doi: 10.1016/S2214-109X(22)00433-8. Epub 2022 Oct 11. Lancet Glob Health. 2022. PMID: 36240807 Free article.